BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 24452366)

  • 1. Rituximab single agent in age-related Epstein-Barr virus associated B cell disorder complicated by autoimmune anemia and pure red cell aplasia.
    Del Principe MI; Cefalo M; Buccisano F; Anemona L; Sarlo C; Di Caprio L; De Santis G; Giacobbi E; Maurillo L; Postorino M; Del Poeta G; Amadori S; Venditti A
    Ann Hematol; 2014 Sep; 93(9):1611-2. PubMed ID: 24452366
    [No Abstract]   [Full Text] [Related]  

  • 2. Treatment of Epstein-Barr virus--associated lymphoproliferative disorder (EBV-PTLD) and pure red cell aplasia (PRCA) with Rituximab following unrelated cord blood transplantation: a case report and literature review.
    Zhu K; Chen J; Chen S
    Hematology; 2005 Oct; 10(5):365-70. PubMed ID: 16273722
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Autoimmune cytopenias in chronic lymphocytic leukemia.
    D'Arena G; Guariglia R; La Rocca F; Trino S; Condelli V; De Martino L; De Feo V; Musto P
    Clin Dev Immunol; 2013; 2013():730131. PubMed ID: 23690826
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Life-threatening complication of Rituximab in a child.
    Bader-Meunier B; Gabolde M; Casadevall N; Seguin G; Tchernia G
    Haematologica; 2002 Dec; 87(12):ECR45. PubMed ID: 12553334
    [No Abstract]   [Full Text] [Related]  

  • 5. Favorable outcome of Epstein-Barr virus-associated B-cell lymphoproliferative disorder complicated by immunoglobulin G4-related disease treated with rituximab-based therapy: a case report.
    Ueda K; Ikeda K; Ogawa K; Sukegawa M; Sano T; Kimura S; Suzuki O; Hashimoto Y; Takeishi Y
    J Med Case Rep; 2016 Aug; 10(1):236. PubMed ID: 27557810
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Successful treatment with rituximab of an Epstein-Barr virus-associated leiomyosarcoma occurring after liver transplantation.
    Jericho H; Weinstein J; Melin-Aldana H; Leuer KC; Wyers M; Alonso EM; Ekong UD
    J Pediatr Gastroenterol Nutr; 2014 Jan; 58(1):e2-4. PubMed ID: 24378523
    [No Abstract]   [Full Text] [Related]  

  • 7. Response to rituximab-based therapy and risk factor analysis in Epstein Barr Virus-related lymphoproliferative disorder after hematopoietic stem cell transplant in children and adults: a study from the Infectious Diseases Working Party of the European Group for Blood and Marrow Transplantation.
    Styczynski J; Gil L; Tridello G; Ljungman P; Donnelly JP; van der Velden W; Omar H; Martino R; Halkes C; Faraci M; Theunissen K; Kalwak K; Hubacek P; Sica S; Nozzoli C; Fagioli F; Matthes S; Diaz MA; Migliavacca M; Balduzzi A; Tomaszewska A; Camara Rde L; van Biezen A; Hoek J; Iacobelli S; Einsele H; Cesaro S;
    Clin Infect Dis; 2013 Sep; 57(6):794-802. PubMed ID: 23771985
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Epstein-Barr virus-associated post-transplant lymphoproliferative disorder of plasma cell type following allogeneic haemopoietic stem cell transplant treated with rituximab.
    Getta B; Kwan J
    Intern Med J; 2014 Aug; 44(8):821. PubMed ID: 25081050
    [No Abstract]   [Full Text] [Related]  

  • 9. Anti-CD20 monoclonal antibody for the treatment of severe, immune-mediated, pure red cell aplasia and hemolytic anemia.
    Zecca M; De Stefano P; Nobili B; Locatelli F
    Blood; 2001 Jun; 97(12):3995-7. PubMed ID: 11389047
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Successful treatment with rituximab for autoimmune hemolytic anemia concomitant with proliferation of Epstein-Barr virus and monoclonal gammopathy in a post-nonmyeloablative stem cell transplant patient.
    Endo T; Nakao S; Koizumi K; Nishio M; Fujimoto K; Sakai T; Kumano K; Obara M; Koike T
    Ann Hematol; 2004 Feb; 83(2):114-6. PubMed ID: 14513283
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Concurrent classical Hodgkin lymphoma and plasmablastic lymphoma in a patient with chronic lymphocytic leukemia/small lymphocytic lymphoma treated with fludarabine: a dimorphic presentation of iatrogenic immunodeficiency-associated lymphoproliferative disorder with evidence suggestive of multiclonal transformability of B cells by Epstein-Barr virus.
    Foo WC; Huang Q; Sebastian S; Hutchinson CB; Burchette J; Wang E
    Hum Pathol; 2010 Dec; 41(12):1802-8. PubMed ID: 20869749
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Successful treatment of acute Epstein-Barr virus infection associated with X-linked lymphoproliferative disorder with rituximab.
    Bond J; Shahdadpuri R; Mc Mahon C; O'marcaigh A; Cotter M; Smith O
    Pediatr Blood Cancer; 2007 Oct; 49(5):761-2. PubMed ID: 17066466
    [No Abstract]   [Full Text] [Related]  

  • 13. Rituximab to treat chronic lymphoproliferative disorder-associated pure red cell aplasia.
    D'Arena G; Vigliotti ML; Dell'Olio M; Villa MR; Mantuano S; Scalzulli PR; La Sala A; Abbadessa A; Mastrullo L; Cascavilla N
    Eur J Haematol; 2009 Mar; 82(3):235-9. PubMed ID: 19067738
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Successful treatment of a patient with Epstein-Barr virus-positive B-cell lymphoproliferative disorder resembling post-transplant lymphoproliferative disorder using single-agent rituximab.
    Maldonado NI; Cabanillas F; Jaffe ES; Raffeld M; Lozada L
    J Clin Oncol; 2011 Aug; 29(22):e658-60. PubMed ID: 21646613
    [No Abstract]   [Full Text] [Related]  

  • 15. Pure red cell aplasia in B-cell lymphoproliferative disorder treated with rituximab: report of two cases and review of the literature.
    Narra K; Borghaei H; Al-Saleem T; Höglund M; Smith MR
    Leuk Res; 2006 Jan; 30(1):109-14. PubMed ID: 16043218
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Follicular lymphoma complicated with autoimmune hemolytic anemia and pure red cell aplasia].
    Nakashima Y; Abe Y; Ohtsuka R; Tachikawa Y; Nagasawa E; Nishimura J; Ohshima K; Nawata H; Muta K
    Rinsho Ketsueki; 2004 Nov; 45(11):1208-10. PubMed ID: 15609689
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Concomitant autoimmune hemolytic anemia and pure red cell aplasia in a patient with chronic lymphocytic leukemia successfully treated with ibrutinib.
    Krečak I; Čengić M; Skorić I; Nakić M; Gverić-Krečak V
    Ann Hematol; 2021 Nov; 100(11):2861-2862. PubMed ID: 34109444
    [No Abstract]   [Full Text] [Related]  

  • 18. Epstein-Barr virus associated diffuse large B-cell lymphoma complicated by autoimmune hemolytic anemia and pure red cell aplasia.
    Katayama H; Takeuchi M; Yoshino T; Munemasa M; Tada A; Soda R; Takahashi K
    Leuk Lymphoma; 2001 Jul; 42(3):539-42. PubMed ID: 11699422
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Epstein-Barr virus-driven lymphoproliferative disorder post-CAMPATH-1H (alemtuzumab) in refractory polymyositis.
    Cooles FA; Jackson GH; Menon G; Isaacs JD
    Rheumatology (Oxford); 2011 Apr; 50(4):810-2. PubMed ID: 21208978
    [No Abstract]   [Full Text] [Related]  

  • 20. Pure red cell aplasia associated with non-Hodgkin's lymphoma and hemolytic anemia.
    Suzuki A; Takahashi T; Taniguchi A; Kotake C; Seo T; Toda T; Kobayashi K; Tsukamoto N; Fukumoto M
    Jpn J Clin Oncol; 1991 Oct; 21(5):384-7. PubMed ID: 1753420
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.